Xiaoyu Tian

No ORCID on file · 4 papers in corpus
other 2026
PharmacoEconomics ·doi:10.1007/s40273-026-01596-2
meta-analysis 2017
Oncotarget ·doi:10.18632/oncotarget.15759

Ovarian reserve reflects a woman's fertility potential. The ABO blood group system is a very stable genetic marker. Although many recent studies have explored the relationship between ABO blood group and ovarian reserve, a consensus has not…

observational 2016
Oncotarget ·doi:10.18632/oncotarget.8245

BACKGROUND: Most cervical cancer patients worldwide receive surgical treatments, and yet the current International Federation of Gynecology and Obstetrics (FIGO) staging system do not consider surgical-pathologic data. We propose a more com…

lab-animal 2014
Oncology research ·doi:10.3727/096504015x14410238486720

Triptorelin, a kind of GnRH agonist, is widely used in the treatment of hormone-responsive cancers in the clinic. This study aimed to discover the underlying mechanism of triptorelin in protection from 5-fluorouracil (5-FU)-induced ovarian …